Pub. Date : 2014 Oct
PMID : 24721791
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | We observed an increased tumorigenicity of bortezomib-resistant MCL cells in vivo, which was associated with plasmacytic differentiation features, like interferon regulatory factor 4 (IRF4) and Blimp-1 upregulation. | Bortezomib | PR domain containing 1, with ZNF domain | Mus musculus |